Virus samples swabbed from noses and throats of flu sufferers across the Asia-Pacific streaming into
Anne Kelso’s Melbourne laboratory may hold clues about how virulent swine flu will be when it resurfaces in Europe and North America this year.
Dozens of germ-laden vials arrive daily at a four-story brick building in inner Melbourne via courier from as far away as the Pacific island of
Palau and the Philippines. Inside, Kelso and colleagues are analyzing the microbes to determine whether they are mutating into a strain resistant to drugs like
Roche Holding AG’s Tamiflu.
“All eyes are on Australia, Chile and the other countries where there’s been a big rise in cases and as our flu season starts to show its face,” Kelso, the center’s director, said in an interview last week. “We expect the season will be getting going now because of the time of the year and particularly the fact that it’s a lot colder in Melbourne.”
Germ War
Tens of thousands of Melbournians are estimated to have caught the new bug, known as A/H1N1, in the past two months, according to Lindsay Grayson, director of infectious diseases at Melbourne’s Austin Hospital, which has diagnosed hundreds of people with the virus.
Unlike seasonal flu, from which the elderly suffer the most death and disease, the new bug is targeting the young and causing potentially fatal complications in otherwise healthy people aged 30 to 50, pregnant women and those with asthma, diabetes and obesity, according to the WHO.The virus has since taken hold in Argentina, Hong Kong,
New Zealand, the Philippines, Singapore and Thailand.
http://www.bloomberg.com/apps/news?pid=20601081&sid=apOlayB70Zyg